Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020-Reference-Cited by-同舟云学术

Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020

Published:2020-10 Issue:5 Volume:87 Page:431-437
ISSN:1297-319X
Container-title:Joint Bone Spine
language:en
Short-container-title:Joint Bone Spine

Author:

Richez Christophe,Flipo René-Marc,Berenbaum Francis,Cantagrel Alain,Claudepierre Pascal,Debiais Françoise,Dieudé Philippe,Goupille Philippe,Roux Christian,Schaeverbeke Thierry,Wendling Daniel,Pham Thao,Thomas Thierry

Publisher

Elsevier BV

Subject

Rheumatology

Reference37 articles.

1. Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases;Richez;Joint Bone Spine,2020

2. Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome;Quartuccio;Joint Bone Spine,2020

3. Old and new antirheumatic drugs for the treatment of COVID-19;Benucci;Joint Bone Spine,2020

4. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review;Sanders;JAMA,2020

5. Ibuprofen, paracetamol, and steam for patients with respiratory tract infections in primary care: pragmatic randomised factorial trial;Little;BMJ,2013

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Features and Outcomes of Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease and Spondyloarthropathies;The Turkish Journal of Gastroenterology;2022-09-21

2. COVID-19 Pandemisinde Kapanma ve Kısıtlamaların Etkileri: Ankilozan Spondilit Hastalarının Bakış Açıları ve Deneyimleri.;Genel Tıp Dergisi;2022-06-15

3. Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic;Gut;2022-04-27

4. The Emerging Era of Interventional Imaging in Rheumatology: An Overview During the Coronavirus Disease-2019 (COVID-19) Pandemic;Open Access Rheumatology: Research and Reviews;2022-04

5. Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era;Advances in Therapy;2022-01-06